Fundz

Akari Therapeutics Plc reported raising $12.3 Million in an initial SEC Form D filing, from an offering of $12.3 Million

PUBLIC · AKTXJul 22, 2021

Amount Raised

$12.3 Million

$12.3 Million sold, per SEC Form D (first sale Jul 22, 2021)

Round Type

Venture

TampaBiotechnologyresearch

Quick answer

Akari Therapeutics raised $12.3 Million in a funding round, dated July 22, 2021. Akari Therapeutics is based in Tampa, Florida, United States.

How much did Akari Therapeutics raise?
Akari Therapeutics raised $12.3 Million in a funding round on July 22, 2021.
What does Akari Therapeutics do?
Akari Therapeutics is an oncology biotech company developing novel antibody drug conjugates (ADCs) with its first payload, PH1, a spliceosome modulator that disrupts RNA splicing in cancer cells.
Where is Akari Therapeutics based and how big is it?
Akari Therapeutics is based in Tampa, Florida, United States. Fundz records about 8 employees.
Who are the decision-makers at Akari Therapeutics?
Fundz holds 3 contacts at Akari Therapeutics, including the UK Finance Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Akari Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Aarvik Therapeutics raised $8.3M on September 2, 2021.
  • Linnaeus Therapeutics raised $4.3M (Seed) on August 24, 2021.
  • Wugen raised $37M on July 23, 2021.
  • Wugen raised $99M on July 23, 2021.
  • Arzeda raised $26M on July 22, 2021.
  • Wugen raised $172M (Funding Round) on July 15, 2021.

Who to call at Akari Therapeutics, and when

A new round usually means Akari Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Akari Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Akari Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Akari Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Akari Therapeutics

Location

401 EAST JACKSON STREET

Tampa, Florida, United States

About

Akari Therapeutics is an oncology biotech company developing novel antibody drug conjugates (ADCs) with its first payload, PH1, a spliceosome modulator that disrupts RNA splicing in cancer cells. Unlike traditional ADC payloads, PH1 induces cancer cell death while activating immune responses, showing robust and durable activity in preclinical models.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Akari Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsClaire C., UK Finance Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Akari Therapeutics's next move

See what Strategic adds

Akari Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.